Federal grants to Ship of Theseus LLC
Ship of Theseus LLC in Norristown, Pennsylvania received $3.4 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cardiovascular Diseases Research, with $3.0 million. In fiscal 2025 it was awarded $2.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.4 million
- Awards5
- Awarded in FY 2025$2.2 million
- Largest award$1.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $293,089 |
| FY 2022 | 1 | $457,450 |
| FY 2023 | 1 | $230,300 |
| FY 2024 | 1 | $213,500 |
| FY 2025 | 2 | $2.2 million |
Programs that fund Ship of Theseus LLC
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 4 | $3.0 million |
| Cancer Treatment Research | 1 | $399,739 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $3.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant - project summary hematopoietic stem cell (HSC) transplants (HSCTS) are considered a potentially curative option for patients with certain cancers of the blood and bone marro | Cardiovascular Diseases Research | August 21, 2025 | $1.8 million |
| Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant - hematopoietic stem cell (HSC) transplants (HSCTS) are considered a potentially curative option for patient | Cardiovascular Diseases Research | August 17, 2022 | $457,450 |
| Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant - hematopoietic stem cell (HSC) transplants (HSCTS) are considered a potentially curative option for patient | Cardiovascular Diseases Research | September 1, 2023 | $443,800 |
| Preclinical development of a tandem cart / hsc transplantation platform for hematologic malignancies - project summary chimeric antigen receptor (CAR) t cell therapy has revolutionized the treatment of hematologic cancers. However, to date, there are only 7 fda-approved car-t therapies, with indicat | Cancer Treatment Research | September 9, 2025 | $399,739 |
| Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant - project summary hematopoietic stem cell (HSC) transplants (HSCTS) are considered a potentially curative option for patients with certain cancers of the blood and bone marro | Cardiovascular Diseases Research | August 6, 2021 | $293,089 |
Questions people ask
How much federal grant money does Ship of Theseus LLC get?
$3.4 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ship of Theseus LLC the most?
The Department of Health and Human Services, with $3.4 million in 5 awards.
What is Ship of Theseus LLC's largest federal grant?
$1.8 million under Cardiovascular Diseases Research, with its first action in the period on August 21, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ship of Theseus LLC?
Its largest are Cardiovascular Diseases Research and Cancer Treatment Research.
Other grant recipients in Norristown
- Montgomery County Intermediate Unit 23
- County of Montgomery
- Montgomery County Housing Authority
- Gaudenzia, Inc
- Norristown Area School District
- Norristown, Borough of
- Family Service of Montgomery County, Pennsylvania
- The Lincoln Center for Family and Youth
Largest federal grant recipients in Pennsylvania · Federal grants in Pennsylvania